ARANESP 130 micrograms, solution for injection in a pre-filled syringe syringe, 0.65 ml
Active ingredients: Darbepoetin alfa
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionsyringe, 0.65 mlintraveineuse;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ARANESP 130 microgrammes, solution injectable en seringue préremplie
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse;sous-cutanée
- Presentation description
- 1 seringue(s) préremplie(s) en verre sécurisée de 0,65 ml avec aiguille(s)
- Marketing authorisation holder
- AMGEN EUROPE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 8 Jun 2010
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64899318CIP73959312CIP133400939593128Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DARBÉPOÉTINE ALFAsolution | 200 microgrammes · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.